VIM and esophageal squamous cell carcinoma: CircGOT1, whose expression is upregulated in esophageal squamous cell cancers, is able to promote downstream GOT1 expression through direct binding to miR-606, which ultimately affects E-cadherin, N-cadherin, and Vimentin expression for cellular EMT [156].